Malta - engleză - Malta Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - tamoxifen citrate - film-coated tablet - tamoxifen citrate 20 mg - endocrine therapy

Malta - engleză - Malta Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - formoterol fumarate, dihydrate - inhalation powder - formoterol fumarate dihydrate 4.5 µg - drugs for obstructive airway diseases

Malta - engleză - Malta Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - formoterol fumarate, dihydrate - inhalation powder - formoterol fumarate dihydrate 9 µg - drugs for obstructive airway diseases

Israel - engleză - Ministry of Health

astrazeneca (israel) ltd - anifrolumab - concentrate for solution for infusion - anifrolumab 150 mg/ml - anifrolumab - saphnelo is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (sle), who are receiving standard therapy.limitations of usethe efficacy of saphnelo has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. use of saphnelo is not recommended in these situations.

Malta - engleză - Malta Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - inhalation powder - terbutaline sulfate 500 µg/spray - drugs for obstructive airway diseases

Israel - engleză - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - powder for inhalation - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler 320/9 mcg/dose is indicated in adults and adolescents, age 12 -17 for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor-agonist) is appropriate:-patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor-agonists.or- patients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptoragonists.chronic obstructive pulmonary disease (copd)symbicort turbuhaler 320/9 mcg/dose is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in i second (fev1) < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy

Malta - engleză - Malta Medicines Authority

astrazeneca ab - bupivacaine hydrochloride 5 mg/ml - solution for injection

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

astrazeneca ab - propranolol hydrochloride - film-coated tablet - 10 milligram(s) - beta blocking agents, non-selective; propranolol

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

astrazeneca ab - budesonide micronised; formoterol fumarate dihydrate (micronised) - pressurised inhalation, suspension - 200 mcg/6 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and budesonide

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

astrazeneca ab - atenolol; chlorthalidone - film-coated tablet - 50 mg/12.5 milligram(s) - beta blocking agents, selective, and other diuretics; atenolol and other diuretics